Teyi Pharmaceutical Group Co Ltd (002728) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.029x

Based on the latest financial reports, Teyi Pharmaceutical Group Co Ltd (002728) has a cash flow conversion efficiency ratio of 0.029x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥52.94 Million ≈ $7.75 Million USD) by net assets (CN¥1.84 Billion ≈ $269.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Teyi Pharmaceutical Group Co Ltd worth for the company's overall valuation and market capitalisation.

Teyi Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Teyi Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Teyi Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Teyi Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Explore 002728 cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Harim Holdings Co. Ltd KQ:003380	0.055x
Paul Hartmann AG F:PHH2	0.021x
PSI Software AG F:PSAN	-0.030x
Arctech Solar Holding Co Ltd SHG:688408	0.071x
Southern Cable Group Bhd KLSE:0225	0.036x
Ulker Biskuvi Sanayi AS IS:ULKER	0.050x
Shenzhen Urovo Technology Co Ltd SHE:300531	0.059x
First Hi-tec Enterprise Co Ltd TWO:5439	0.178x

Annual Cash Flow Conversion Efficiency for Teyi Pharmaceutical Group Co Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Teyi Pharmaceutical Group Co Ltd from 2009 to 2025. View today's stock price for Teyi Pharmaceutical Group Co Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.84 Billion ≈ $269.06 Million	CN¥244.88 Million ≈ $35.83 Million	0.133x	+1142.38%
2024-12-31	CN¥1.76 Billion ≈ $258.27 Million	CN¥-22.55 Million ≈ $-3.30 Million	-0.013x	-112.94%
2023-12-31	CN¥2.01 Billion ≈ $294.23 Million	CN¥198.56 Million ≈ $29.06 Million	0.099x	-62.72%
2022-12-31	CN¥1.40 Billion ≈ $205.32 Million	CN¥371.66 Million ≈ $54.39 Million	0.265x	+30.13%
2021-12-31	CN¥1.26 Billion ≈ $184.62 Million	CN¥256.81 Million ≈ $37.58 Million	0.204x	+30.14%
2020-12-31	CN¥1.08 Billion ≈ $158.10 Million	CN¥168.99 Million ≈ $24.73 Million	0.156x	-18.63%
2019-12-31	CN¥1.15 Billion ≈ $168.73 Million	CN¥221.64 Million ≈ $32.43 Million	0.192x	+13.64%
2018-12-31	CN¥1.11 Billion ≈ $162.60 Million	CN¥187.97 Million ≈ $27.51 Million	0.169x	+71.34%
2017-12-31	CN¥1.04 Billion ≈ $152.60 Million	CN¥102.96 Million ≈ $15.07 Million	0.099x	-13.59%
2016-12-31	CN¥886.57 Million ≈ $129.73 Million	CN¥101.30 Million ≈ $14.82 Million	0.114x	+33.44%
2015-12-31	CN¥804.30 Million ≈ $117.69 Million	CN¥68.87 Million ≈ $10.08 Million	0.086x	+9.84%
2014-12-31	CN¥735.64 Million ≈ $107.65 Million	CN¥57.35 Million ≈ $8.39 Million	0.078x	-63.23%
2013-12-31	CN¥350.14 Million ≈ $51.24 Million	CN¥74.23 Million ≈ $10.86 Million	0.212x	-42.12%
2012-12-31	CN¥285.34 Million ≈ $41.75 Million	CN¥104.50 Million ≈ $15.29 Million	0.366x	+18.31%
2011-12-31	CN¥225.51 Million ≈ $33.00 Million	CN¥69.81 Million ≈ $10.21 Million	0.310x	+12.70%
2010-12-31	CN¥170.81 Million ≈ $25.00 Million	CN¥46.92 Million ≈ $6.87 Million	0.275x	+26.99%
2009-12-31	CN¥103.18 Million ≈ $15.10 Million	CN¥22.32 Million ≈ $3.27 Million	0.216x	--

About Teyi Pharmaceutical Group Co Ltd

SHE:002728 China Drug Manufacturers - Specialty & Generic

Market Cap

$724.09 Million

CN¥4.95 Billion CNY

Market Cap Rank

#10480 Global

#2837 in China

Share Price

CN¥9.64

Change (1 day)

+3.88%

52-Week Range

CN¥8.00 - CN¥15.21

All Time High

CN¥129.24